Evans syndrome natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
| Line 16: | Line 18: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
Revision as of 14:29, 21 September 2012
|
Evans syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Evans syndrome natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Evans syndrome natural history, complications and prognosis |
|
FDA on Evans syndrome natural history, complications and prognosis |
|
CDC on Evans syndrome natural history, complications and prognosis |
|
Evans syndrome natural history, complications and prognosis in the news |
|
Blogs on Evans syndrome natural history, complications and prognosis |
|
Risk calculators and risk factors for Evans syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Prognosis
Given the fact that the signs and symptoms of this disease are related directly to the abnormal laboratory findings, the prognosis depends on the patient’s response to treatment. Spontaneous remissions of each of the individual component conditions have been reported. If the child responds well to the treatment and the levels of platelets and red blood cells increase, the child can expect to live a normal life. Medications will be needed life long, and laboratory tests will need to be constantly monitored to detect any abnormal changes so that treatment can be adjusted.
In more serious cases it can massively reduce life span and is seriously life threatening.
Evan's Syndrome is rare, serious, and has a reported mortality rate of just under 18%.